166 related articles for article (PubMed ID: 28258910)
1. [Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study].
Léon P; Cancel-Tassin G; Koutlidis N; Calves J; Funes de la Vega M; Fournier G; Valeri A; Cormier L; Larré S; Cussenot O
Prog Urol; 2017 Mar; 27(3):158-165. PubMed ID: 28258910
[TBL] [Abstract][Full Text] [Related]
2. [Management of low-risk prostate cancer].
Rozet F; Bastide C; Beuzeboc P; Cormier L; Fromont G; Hennequin C; Mongiat-Artus P; Peyromaure M; Renard-Penna R; Richaud P; Salomon L; Soulié M;
Prog Urol; 2015 Jan; 25(1):1-10. PubMed ID: 25454776
[TBL] [Abstract][Full Text] [Related]
3. Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalities.
Leyh-Bannurah SR; Abou-Haidar H; Dell'Oglio P; Schiffmann J; Tian Z; Heinzer H; Huland H; Graefen M; Budäus L; Karakiewicz PI
BJU Int; 2017 May; 119(5):692-699. PubMed ID: 27367469
[TBL] [Abstract][Full Text] [Related]
4. Optimizing D'Amico risk groups in radical prostatectomy through the addition of magnetic resonance imaging data.
Algarra R; Zudaire B; Tienza A; Velis JM; Rincón A; Pascual I; Zudaire J
Actas Urol Esp; 2014 Nov; 38(9):594-9. PubMed ID: 24791621
[TBL] [Abstract][Full Text] [Related]
5. External validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese patients receiving radical prostatectomy.
Ishizaki F; Hoque MA; Nishiyama T; Kawasaki T; Kasahara T; Hara N; Takizawa I; Saito T; Kitamura Y; Akazawa K; Takahashi K
Jpn J Clin Oncol; 2011 Nov; 41(11):1259-64. PubMed ID: 21940731
[TBL] [Abstract][Full Text] [Related]
6. Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations.
Leyh-Bannurah SR; Karakiewicz PI; Pompe RS; Preisser F; Zaffuto E; Dell'Oglio P; Briganti A; Nafez O; Fisch M; Steuber T; Graefen M; Budäus L
World J Urol; 2019 Mar; 37(3):469-479. PubMed ID: 29992380
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer in 432 men aged <50 years in the prostate-specific antigen era: a new outlook.
Gielchinsky I; Chang J; Cusick T; Delprado W; Nguyen Q; Yuen C; Savdie R; Böhm M; Haynes AM; Scheltema MJ; Stricker PD
BJU Int; 2018 Nov; 122 Suppl 5():35-41. PubMed ID: 30303599
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of radical prostatectomy versus external beam radiotherapy (75.6 Gy) combined with hormone therapy for prostate cancer of intermediate D'Amico risk classification].
Boissier R; Karsenty G; Muracciole X; Daniel L; Delaporte V; Maurin C; Coulange C; Lechevallier E
Prog Urol; 2013 Sep; 23(10):861-8. PubMed ID: 24034798
[TBL] [Abstract][Full Text] [Related]
9. Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models.
Boehm K; Larcher A; Beyer B; Tian Z; Tilki D; Steuber T; Karakiewicz PI; Heinzer H; Graefen M; Budäus L
Eur Urol; 2016 Jun; 69(6):1038-43. PubMed ID: 26272236
[TBL] [Abstract][Full Text] [Related]
10. Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.
Narita S; Mitsuzuka K; Tsuchiya N; Koie T; Kawamura S; Ohyama C; Tochigi T; Yamaguchi T; Arai Y; Habuchi T;
Int J Urol; 2015 Nov; 22(11):1029-35. PubMed ID: 26290306
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
12. The Treatment of Localized Prostate Cancer in Everyday Practice in Germany.
Herden J; Ansmann L; Ernstmann N; Schnell D; Weißbac L
Dtsch Arztebl Int; 2016 May; 113(19):329-36. PubMed ID: 27232362
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?
Turkbey B; Mani H; Aras O; Ho J; Hoang A; Rastinehad AR; Agarwal H; Shah V; Bernardo M; Pang Y; Daar D; McKinney YL; Linehan WM; Kaushal A; Merino MJ; Wood BJ; Pinto PA; Choyke PL
Radiology; 2013 Jul; 268(1):144-52. PubMed ID: 23468576
[TBL] [Abstract][Full Text] [Related]
14. [High-risk prostate cancer surgical margins during robot-assisted radical prostatectomy].
Duperron C; Moulin M; Koutlidis N; Mourey E; Cormier L
Prog Urol; 2015 Jun; 25(7):390-5. PubMed ID: 25759079
[TBL] [Abstract][Full Text] [Related]
15. A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients.
Leyh-Bannurah SR; Dell'Oglio P; Tian Z; Schiffmann J; Shariat SF; Suardi N; Francesco M; Alberto B; Heinzer H; Huland H; Graefen M; Budäus L; Karakiewicz PI
World J Urol; 2017 Feb; 35(2):189-197. PubMed ID: 27289238
[TBL] [Abstract][Full Text] [Related]
16. Association between Basal Total Testosterone Levels and Prostate Cancer D'Amico Risk Classes.
Tafuri A; Sebben M; Pirozzi M; Processali T; Shakir A; Rizzetto R; Amigoni N; Brunelli M; Baccaglini W; Migliorini F; Siracusano S; Artibani W; Porcaro AB
Urol Int; 2020; 104(9-10):716-723. PubMed ID: 32460298
[TBL] [Abstract][Full Text] [Related]
17. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
Mitchell JA; Cooperberg MR; Elkin EP; Lubeck DP; Mehta SS; Kane CJ; Carroll PR
J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
[TBL] [Abstract][Full Text] [Related]
18. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.
Song SH; Pak S; Park S; Song C; Jeong IG; Choi HJ; Kim JK; Cho KS; Kim CS; Ahn H
J Urol; 2014 Aug; 192(2):402-8. PubMed ID: 24631106
[TBL] [Abstract][Full Text] [Related]
19. Trends in initial management of prostate cancer in New Hampshire.
Ingimarsson JP; Celaya MO; Laviolette M; Rees JR; Hyams ES
Cancer Causes Control; 2015 Jun; 26(6):923-9. PubMed ID: 25840558
[TBL] [Abstract][Full Text] [Related]
20. Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer.
Renard-Penna R; Cancel-Tassin G; Comperat E; Roupret M; Mozer P; Cussenot O
World J Urol; 2015 Jul; 33(7):929-36. PubMed ID: 25944677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
